Cartesian Therapeutics, Inc. (RNAC) Operating Lease, Right-of-Use Asset USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cartesian Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from 2019 to 2024.
  • Cartesian Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $9.56M, a 14.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly Data (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $9.56M -$1.65M -14.7% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $10.1M -$1.55M -13.3% Dec 31, 2023 10-Q 2024-05-08
Q3 2023 $10.3M -$1.72M -14.2% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $10.8M +$1.54M +16.6% Jun 30, 2023 10-Q 2023-08-17
Q1 2023 $11.2M +$1.67M +17.5% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $11.6M +$1.79M +18.2% Dec 31, 2022 10-K 2024-03-07
Q3 2022 $12.1M +$1.94M +19.2% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $9.24M -$1.16M -11.2% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $9.54M -$1.14M -10.7% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $9.83M -$1.12M -10.2% Dec 31, 2021 10-K 2023-03-02
Q3 2021 $10.1M -$1.1M -9.8% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $10.4M -$1.08M -9.37% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $10.7M -$1.17M -9.88% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $10.9M +$10.6M +3537% Dec 31, 2020 10-K 2022-03-10
Q3 2020 $11.2M +$10.6M +1788% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $11.5M +$10.6M +1207% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $11.8M +$10.7M +926% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $301K Dec 31, 2019 10-K 2021-03-12
Q3 2019 $594K Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $878K Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $1.16M Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.